Correction to: The Clinical Course of Cirrhosis: The Importance of Multistate Models and Competing Risks Analysis (Hepatology, (2015), 62, (292-302), 10.1002/hep.27598);The Clinical Course of Cirrhosis: The Importance of Multistate Models and Competing Risks Analysis

Hepatology

Volumn 62, Issue 1, 2015, Pages 292-302

  Jepsen, Peter ^a   Vilstrup, Hendrik ^a   Andersen, Per Kragh ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL STUDY; COMPENSATED LIVER CIRRHOSIS; COMPUTER PROGRAM; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; DISEASE MODEL; FOLLOW UP; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; MEDICAL DECISION MAKING; OCCUPATIONAL HEALTH; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REVIEW; RISK ASSESSMENT; RISK FACTOR; THEORETICAL MODEL;

DISEASE PROGRESSION; HUMANS; LIVER CIRRHOSIS; MODELS, THEORETICAL; PROGNOSIS; RISK ASSESSMENT; SOFTWARE;

EID: 84933182808     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.29141     Document Type: Erratum

References (29)

1. Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012;41:861-870.
2. Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. The clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study. Hepatology 2010;51:1675-1682.
3. Rosselli M, MacNaughtan J, Jalan R, Pinzani M. Beyond scoring: a modern interpretation of disease progression in chronic liver disease. Gut 2013;62:1234-1241.
4. Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology 2010;51:1445-1449.
5. Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010;139:1246-1256.
6. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-231.
7. Andersen PK, Abildstrøm SZ, Rosthøj S. Competing risks as a multi-state model. Stat Methods Med Res 2002;11:203-215.
8. Bakoyannis G, Touloumi G. Practical methods for competing risks data: a review. Stat Methods Med Res 2012;21:257-272.
9. Andersen PK, Keiding N. Interpretability and importance of functionals in competing risks and multistate models. Stat Med 2012;31:1074-1088.
10. Kalbfleisch JD, Prentice RL. The Statical Analysis of Failure Time Data, 1st ed. New York: John Wiley & Sons; 1980.
11. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706.
12. Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann Intern Med 2012;156:841-847.
13. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-943.
14. D'Amico G, Pasta L, Morabito A, D'Amico M, Caltagirone M, Malizia G, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther 2014;39:1180-1193.
15. Sherman M. Hepatocellular carcinoma: screening and staging. Clin Liver Dis 2011;15:323-334.
16. Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res 2002;11:91-115.
17. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007;317:121-124.
18. Andersen PK, Perme MP. Pseudo-observations in survival analysis. Stat Methods Med Res 2010;19:71-99.
19. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
20. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007;40:381-387.
21. R Development Core Team. R: a language and environment for statistical computing. Vienna: the R Foundation for Statistical Computing; 2012.
22. Therneau T. A package for survival analysis in S (R package version 2.36-14). 2012.
23. Gray B. cmprsk: subdistribution analysis of competing risks (R package version 2.2-4). 2013.
24. st ed. Chichester, UK: John Wiley & Sons; 2006.
25. Latouche A, Beyersmann J, Fine JP. Comments on 'Analysing and interpreting competing risk data' by M. Pintilie. Stat Med 2007;26:3676-3679.
26. Ferguson N, Datta S, Brock G. msSurv: an R package for nonparametric estimation of multistate models. J Stat Softw 2012;50:1-24.
27. de Wreede LC, Fiocco M, Putter H. The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models. Comput Methods Programs Biomed 2010;99:261-274.
28. Lin G, So Y, Johnston G. Analyzing survival data with competing risks using SAS® software. Available at: http://support.sas.com/resources/papers/proceedings12/344-2012.pdf. Accessed August 12, 2014.
29. Last JM. A Dictionary of Epidemiology, 4th ed. New York: Oxford University Press; 2001.